A041910 Share Price Performance
₩6,890.00
870.00 (14.45%)
Price ₩6,890.00
Share Price₩6,890.00
A041910 Community Narratives
There are no narratives available yet.
Recent A041910 News & Updates
No updates
Polaris AI Pharma Corp. Key Details
Last Reported Earnings
Sep 30, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Polaris AI Pharma Corp. Competitors
About A041910
- Founded
- 1996
- Employees
- n/a
- CEO
- WebsiteView website
Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea.
South Korean Market Performance
- 7 Days: -2.5%
- 3 Months: 19.8%
- 1 Year: 13.3%
- Year to Date: 27.4%
Over the last 7 days, the market has dropped 2.5%, driven by a decline of 8.3% in the Financials sector. In contrast to the last week, the market is actually up 13% over the past year. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading